Researchers identified existing medications that target novel pathways in E. coli, offering a potential solution to the growing antibiotic resistance threat.
By identifying the types of molecules that accumulate inside P. aeruginosa, researchers drew a roadmap for new antibiotic development for combatting these deadly pathogens.
Scientists created a pill that, when swallowed, collects snapshots of the gastrointestinal microbiome, revealing striking differences along the GI tract.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.